» Authors » Anna Felisiak-Golabek

Anna Felisiak-Golabek

Explore the profile of Anna Felisiak-Golabek including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 21
Citations 382
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Lasota J, Chlopek M, Wasag B, Kowalik A, Christiansen J, Lamoureux J, et al.
Am J Surg Pathol . 2020 Aug; 44(9):1224-1234. PMID: 32804454
This study determined the frequency and the clinicopathologic and genetic features of colorectal carcinomas driven by oncogenic fusions of the anaplastic lymphoma kinase gene (ALK). Of the 8150 screened tumors,...
2.
Lasota J, Chlopek M, Lamoureux J, Christiansen J, Kowalik A, Wasag B, et al.
Am J Surg Pathol . 2019 Oct; 44(2):162-173. PMID: 31567189
This study was undertaken to determine the frequency, and the clinicopathologic and genetic features, of colon cancers driven by neurotrophic receptor tyrosine kinase (NTRK) gene fusions. Of the 7008 tumors...
3.
Trebinska-Stryjewska A, Szafron L, Rembiszewska A, Wakula M, Tabor S, Sienkiewicz R, et al.
J Oncol . 2019 May; 2019:6375025. PMID: 31093284
HAX1 is an antiapoptotic factor involved in the regulation of cell migration and calcium homeostasis, overexpressed in several cancers, including breast cancer. It has been suggested that HAX1 is also...
4.
Lasota J, Kowalik A, Felisiak-Golabek A, Zieba S, Waloszczyk P, Masiuk M, et al.
Mod Pathol . 2019 Feb; 32(7):957-966. PMID: 30760858
Primary malignant melanoma of esophagus is very rare, and its clinicopathologic and genetic features have not been extensively investigated. In this study, 20 tumors from 14 male and 6 female...
5.
Miettinen M, Felisiak-Golabek A, Luina Contreras A, Glod J, Kaplan R, Killian J, et al.
Hum Pathol . 2019 Jan; 86:57-65. PMID: 30633925
Many sarcomas contain gene fusions that can be pathogenetic mechanisms and diagnostic markers. In this article we review selected fusion sarcomas and techniques for their detection. CIC-DUX4 fusion sarcoma is...
6.
Felisiak-Golabek A, Inaguma S, Kowalik A, Wasag B, Wang Z, Zieba S, et al.
Appl Immunohistochem Mol Morphol . 2017 Dec; 26(1):40-45. PMID: 29206715
HRAS, KRAS, and NRAS, highly homologous proteins, are often mutationally activated in cancer. Usually, mutations cluster in codons 12, 13, and 61 and are detected by molecular genetic testing of...
7.
Inaguma S, Lasota J, Felisiak-Golabek A, Kowalik A, Wang Z, Zieba S, et al.
J Pathol Clin Res . 2017 Nov; 3(4):268-278. PMID: 29085667
Aberrant PD-L1 (CD274) expression has been described in different types of tumour and linked to tumour aggressiveness and a poor prognosis. In primary colorectal carcinomas (CRCs), CD274 expression was reported...
8.
Lasota J, Kowalik A, Felisiak-Golabek A, Zieba S, Wang Z, Miettinen M
Appl Immunohistochem Mol Morphol . 2017 Aug; 27(1):54-58. PMID: 28777148
A great majority of gastrointestinal stromal tumors (GISTs) are primarily driven by gain-of-function KIT receptor tyrosine kinase mutations that subsequently lead to activation of phosphatidiylinositol 3-kinase (PI3K)/mammalian target of rapamycin...
9.
Lasota J, Kowalik A, Felisiak-Golabek A, Inaguma S, Wang Z, Pieciak L, et al.
Arch Pathol Lab Med . 2017 Mar; 141(4):564-568. PMID: 28353383
Context: - NRAS is a member of the RAS family oncoproteins implicated in cancer. Gain-of-function NRAS mutations were reported in a subset of colorectal cancers. These mutations occur at codons...
10.
Miettinen M, Felisiak-Golabek A, Wang Z, Inaguma S, Lasota J
Am J Surg Pathol . 2017 Mar; 41(5):577-585. PMID: 28288036
Most gastrointestinal stromal tumors (GISTs) occur in the tubular gastrointestinal (GI) tract, but some present apparently outside the GI tract. In this study, we analyzed 112 GISTs located in the...